| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +66.67% | -4.62% | +0.92% | -5.54% | -1.84% | — |
| 14d | 6 | +16.67% | -10.13% | -0.18% | -9.95% | -7.13% | — |
| 30d | 6 | +33.33% | -14.57% | -0.29% | -14.28% | -15.21% | — |
| 60d | 6 | +33.33% | -10.54% | +1.20% | -11.73% | -21.11% | — |
| 90d | 6 | +33.33% | -21.23% | +0.98% | -22.21% | -23.88% | — |
| 180d | 6 | +16.67% | -54.85% | +3.38% | -58.23% | -57.47% | — |
| 1y | 6 | +0.00% | -82.21% | +13.87% | -96.08% | -97.03% | — |
| 2y | 6 | +0.00% | -95.58% | +24.82% | -120.40% | -121.42% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 4,881 | — | — | 4,881 | Nov 17, 2025 | Nov 19, 2025 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 241.572 | Apr 8, 2024 | Apr 10, 2024 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 201.572 | Apr 8, 2024 | Apr 10, 2024 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 66,666 | $0.30 | $20.0K | 103,438 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 66,666 | — | — | 161,572 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 66,666 | — | — | 94,906 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 27,000 | $1.27 | $34.2K | 36,772 | Aug 22, 2023 | Aug 23, 2023 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 521 | — | — | 9,772 | Apr 28, 2023 | May 1, 2023 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 521 | — | — | 28,248 | Apr 28, 2023 | May 1, 2023 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 3,100 | $3.20 | $9.9K | 9,251 | Apr 17, 2023 | Apr 17, 2023 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 6,067 | — | — | 28,768 | Mar 29, 2023 | Mar 31, 2023 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 681,000 | Apr 28, 2022 | Apr 29, 2022 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 33,000 | $0.31 | $10.2K | 184,500 | Mar 11, 2022 | Mar 14, 2022 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 5,000 | $0.94 | $4.7K | 151,500 | Dec 6, 2021 | Dec 6, 2021 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 4,500 | $1.15 | $5.2K | 146,500 | Nov 19, 2021 | Nov 19, 2021 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 131,000 | — | — | 431,000 | Feb 5, 2021 | Feb 9, 2021 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 142,000 | $2.04 | $289.7K | 142,000 | Aug 24, 2020 | Aug 25, 2020 ↗ | View → |